How should a female patient with a short‑segment myocardial bridge of the proximal left anterior descending artery be managed?

Management of Short-Segment Myocardial Bridging of Proximal LAD

For a female patient with a short-segment myocardial bridge of the proximal LAD, initiate beta-blocker therapy as first-line treatment if she is symptomatic; if asymptomatic, observation alone is appropriate as myocardial bridging is typically a benign finding that does not require intervention.

Initial Assessment and Risk Stratification

The critical first step is determining whether the myocardial bridge is causing symptoms or hemodynamic consequences. Myocardial bridging, particularly of the LAD, is commonly an incidental finding that remains clinically silent throughout life 1, 2.

Key clinical features to assess:

• Exertional chest pain or angina - the hallmark symptom when MB becomes clinically significant
• Exercise-induced symptoms - MB compression is dynamic and worsens with increased adrenergic tone during physical activity 1
• Arrhythmias or syncope - rare but can occur with severe ischemia
• Prior cardiac events - unstable angina, myocardial infarction, or ventricular arrhythmias 1

Management Algorithm

If Asymptomatic:

Observation is the appropriate strategy. The 2024 ESC guidelines for chronic coronary syndromes do not specifically address myocardial bridging as an indication for revascularization 3. Most myocardial bridges remain benign anatomical variants that never cause clinical problems 4, 2.

If Symptomatic:

Step 1: Medical Therapy (First-Line)

Beta-blockers are the cornerstone of medical management for symptomatic myocardial bridging 1. They reduce heart rate, decrease myocardial contractility, and diminish the dynamic systolic compression of the tunneled artery segment.

• Start with a beta-blocker (e.g., metoprolol, atenolol, or bisoprolol)
• Calcium channel blockers can be added as adjunctive therapy 1
• Avoid nitrates - they can paradoxically worsen symptoms by increasing heart rate and contractility

Step 2: Functional Assessment if Medical Therapy Fails

If symptoms persist despite optimal medical therapy, advanced diagnostic evaluation is warranted 5:

• Fractional flow reserve (FFR) or instantaneous wave-free ratio (iwFR) to assess hemodynamic significance 3, 5
• Intravascular ultrasound (IVUS) to evaluate the degree of systolic compression and plaque burden 6
• Stress imaging to document ischemia in the LAD territory
• Optical coherence tomography (OCT) for detailed visualization of the bridged segment 5

Critical threshold: FFR ≤0.80 or iwFR ≤0.89 indicates hemodynamically significant compression requiring intervention 5

Step 3: Invasive Treatment (When Medical Therapy Fails)

Surgical unroofing (myotomy) is the definitive treatment for symptomatic, medically refractory myocardial bridging with documented hemodynamic significance 6, 5, 7.

• Surgical unroofing involves dividing the overlying myocardial muscle to release the tunneled artery
• Results in complete symptom resolution in appropriately selected patients 6, 5
• PCI with stenting is NOT recommended - high restenosis rates, risk of stent fracture, and potential for accelerated atherosclerosis in the bridged segment
• CABG is generally not indicated unless there is coexisting significant coronary disease requiring revascularization 7

Important Caveats and Pitfalls

Avoid overtreatment: The vast majority of myocardial bridges are benign. The 2024 ESC guidelines emphasize that revascularization for proximal LAD disease requires either symptoms refractory to medical therapy or documented ischemia 3. This same principle applies to myocardial bridging.

Functional assessment is essential: Angiographic appearance alone can be misleading. The degree of systolic compression on angiography does not always correlate with hemodynamic significance 8. Always confirm ischemia with functional testing before considering invasive treatment 5.

Beta-blocker intolerance: Some patients cannot tolerate beta-blockers due to hypotension, bradycardia, or fatigue 6. In these cases, proceed directly to functional assessment if symptoms are limiting quality of life.

Atherosclerosis at the bridge site: Myocardial bridges can predispose to atherosclerotic plaque formation at the entrance and exit zones due to altered shear stress 1. This may complicate the clinical picture and require careful evaluation to distinguish fixed stenosis from dynamic compression 8.

Surgical considerations: If surgical unroofing is performed, patch plasty with internal thoracic artery may be necessary if the unroofed segment appears thin or spastic 7. This prevents residual stenosis and ensures durable results.